Optimizing treatment of HER2-positive breast cancer

William J. Gradishar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Optimizing treatment of HER2-positive breast cancer'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science